[LXRX] YoY Quarter Result on 31-Dec-2019 [#Q4]

Stock
[LXRX] Lexicon Pharmaceuticals, Inc.
Announcement Date
12-Mar-2020
Financial Year
2019
Quarter
31-Dec-2019 [#Q4]
Profit Trend
QoQ- -122.62%
YoY- -204.74%
Quarter Report
LXRX's Result
LXRX's Financial Summary
View:
Show?
Quarter Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 28 14 199 8,727 17,071 33,047 23,037 -67.31%
PBT -30,494 -25,611 -5,495 -51,138 -16,781 -32,387 -32,419 -1.01%
Tax 216 -14 -174 335 -102 -4,009 37 34.16%
NP -30,710 -25,611 -5,495 -51,138 -16,781 -28,378 -32,419 -0.89%
Tax Rate - - - - - - - -
Total Cost 30,738 25,625 5,694 59,865 33,852 61,425 55,456 -9.36%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin -109,678.57 -182,935.71 -2,761.31 -585.97 -98.30 -85.87 -140.73 203.20%
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -0.16 -0.17 -0.04 -0.48 -0.16 -0.27 -0.31 -10.43%
EPS Diluted -0.16 -0.17 -0.04 -0.48 -0.16 -0.27 -0.31 -10.43%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.